DMKJ
MCRB icon

David M. Knott Jr’s Seres Therapeutics MCRB Stock Holding History

David M. Knott Jr’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,537
Closed -$519K – 117
2023
Q4 		$519K Buy
18,537
+15,037
+430% +$395K 0.2% 45
2023
Q3 		$167K Sell
3,500
-20,000
-85% -$1.53M 0.06% 69
2023
Q2 		$2.25M Buy
23,500
+7,750
+49% +$843K 0.9% 24
2023
Q1 		$1.79M Buy
15,750
+5,745
+57% +$621K 0.7% 28
2022
Q4 		$1.12M Buy
10,005
+4,505
+82% +$604K 0.42% 43
2022
Q3 		$706K Buy
+5,500
New +$563K 0.3% 57

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

David M. Knott Jr's MCRB Position: Q1 2024 in Review

David M. Knott Jr sold out of Seres Therapeutics (MCRB) in Q1 2024, closing a stake of 18,537 shares — an estimated $519K sold.

David M. Knott Jr first reported a position in MCRB in Q3 2022 and held it in 6 quarters. The position peaked at $2.25M in Q2 2023. 99 funds tracked by Wall St. Rank hold MCRB as of Q1 2024.

  • David M. Knott Jr reported no remaining Seres Therapeutics position as of Q1 2024 after selling out during the quarter.
  • David M. Knott Jr sold 18,537 Seres Therapeutics shares in Q1 2024, an estimated $519K.
  • David M. Knott Jr first reported a position in Seres Therapeutics in Q3 2022 and held it in 6 quarters.
  • David M. Knott Jr's Seres Therapeutics position peaked at $2.25M in Q2 2023.
  • 99 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2024.

Based on David M. Knott Jr's 13F filing for Q1 2024, filed 14 May 2024.